ES2038725T3 - Empleo de una sustancia auxiliar a base de ciclopeptidos y procedimiento para producir un preparado que la contiene. - Google Patents

Empleo de una sustancia auxiliar a base de ciclopeptidos y procedimiento para producir un preparado que la contiene.

Info

Publication number
ES2038725T3
ES2038725T3 ES198888112611T ES88112611T ES2038725T3 ES 2038725 T3 ES2038725 T3 ES 2038725T3 ES 198888112611 T ES198888112611 T ES 198888112611T ES 88112611 T ES88112611 T ES 88112611T ES 2038725 T3 ES2038725 T3 ES 2038725T3
Authority
ES
Spain
Prior art keywords
denotes
amino acid
cyclopeptides
procedure
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888112611T
Other languages
English (en)
Inventor
Jurgen Kurt Dr. Sandow
Rainer Dr. Schmiedel
Klaus Dr. Wirth
Hans Peter Prof. Dr. Merkle
Susanne Raehs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2038725T3 publication Critical patent/ES2038725T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

LA INVENCION TRATA DE LA UTILIZACION DE MATERIALES AUXILIARES DE LA FORMULA(I) DONDE B ES UN AMINOACIDO BASICO, A/B UN AMINOACIDO BASICO O ACIDO, X ES UN AMINOACIDO NEUTRO E HIDROFILO, L ES UN AMINOACIDO NEUTRO LIPOFILO Y R ES HIDROGENO O UN RESTO ACILO, CUYAS SALES CONTRACTUALES FISIOLOGICAS A LA ESTIMULACION DE LA RESORCION DE PEPTIDOS Y PROTEINAS POR APLICACION SOBRE LAS MUCOSAS ASI COMO LA PREPARACION FARMACEUTICA CONTIENEN UNA CANTIDAD EFICAZ FARMACOLOGICA DE UNO O MAS PEPTIDOS O PROTEINAS ASI COMO UNA MATERIA AUXILIAR DE LA FORMULA GENERAL ARRIBA INDICADA.
ES198888112611T 1987-08-07 1988-08-03 Empleo de una sustancia auxiliar a base de ciclopeptidos y procedimiento para producir un preparado que la contiene. Expired - Lifetime ES2038725T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873726324 DE3726324A1 (de) 1987-08-07 1987-08-07 Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute

Publications (1)

Publication Number Publication Date
ES2038725T3 true ES2038725T3 (es) 1993-08-01

Family

ID=6333298

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888112611T Expired - Lifetime ES2038725T3 (es) 1987-08-07 1988-08-03 Empleo de una sustancia auxiliar a base de ciclopeptidos y procedimiento para producir un preparado que la contiene.

Country Status (19)

Country Link
US (1) US5091365A (es)
EP (1) EP0302466B1 (es)
JP (1) JP2764930B2 (es)
KR (1) KR970004039B1 (es)
AT (1) ATE69556T1 (es)
AU (1) AU608878B2 (es)
CA (1) CA1331131C (es)
DE (2) DE3726324A1 (es)
DK (1) DK168273B1 (es)
ES (1) ES2038725T3 (es)
FI (1) FI883643A (es)
GR (1) GR3003733T3 (es)
HU (1) HU199301B (es)
IE (1) IE60871B1 (es)
IL (1) IL87362A0 (es)
NO (1) NO179094C (es)
NZ (1) NZ225715A (es)
PT (1) PT88192B (es)
ZA (1) ZA885724B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2151838A1 (es) * 1997-09-05 2001-01-01 Alfa Wassermann Spa Composiciones farmaceuticas que contienen calcitonina en un dosificador de pulverizado para administracion intranasal.

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW274552B (es) * 1992-05-26 1996-04-21 Hoechst Ag
DE69424940T2 (de) * 1993-06-29 2000-12-28 Ferring B.V., Hoofdorp Synthese zyklischer peptide
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
KR100611559B1 (ko) * 1998-05-08 2007-04-25 동아제약주식회사 칼시토닌을 함유한 비강투여용 약제학적 조성물
SE514606C2 (sv) * 1998-08-26 2001-03-19 Laekartjaenster I Vaestsverige Läkemedel innehållande GnRH-analoger för behandling av schizofreni
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
CN109153712B (zh) 2016-04-19 2022-09-16 格里芬制药国际公司 Peg化生物活性肽及其用途
US20220226479A1 (en) * 2019-03-25 2022-07-21 University Of Tsukuba Cell layer permeation promoter. composition for facilitating drug absorption. and pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171774D1 (en) * 1980-03-31 1985-09-19 Teijin Ltd Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS58140026A (ja) * 1982-01-14 1983-08-19 Toyo Jozo Co Ltd 吸収性良好な製剤
CA1188987A (en) * 1981-03-06 1985-06-18 Masataka Morishita Preparation having excellent absorption property
US4568665A (en) 1982-06-25 1986-02-04 Mitchell David C Protein compounds
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
DE3532074A1 (de) * 1985-09-09 1987-03-12 Berlin Chemie Veb Resorptionsvermittler fuer biologisch aktive peptide

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2151838A1 (es) * 1997-09-05 2001-01-01 Alfa Wassermann Spa Composiciones farmaceuticas que contienen calcitonina en un dosificador de pulverizado para administracion intranasal.

Also Published As

Publication number Publication date
IL87362A0 (en) 1989-01-31
DK168273B1 (da) 1994-03-07
CA1331131C (en) 1994-08-02
KR970004039B1 (ko) 1997-03-24
DK440888D0 (da) 1988-08-05
NO883468L (no) 1989-02-08
ATE69556T1 (de) 1991-12-15
NO179094B (no) 1996-04-29
KR890003409A (ko) 1989-04-14
PT88192B (pt) 1995-03-01
JPS6466128A (en) 1989-03-13
HUT47599A (en) 1989-03-28
NO179094C (no) 1996-08-07
FI883643A (fi) 1989-02-08
IE882408L (en) 1989-02-07
JP2764930B2 (ja) 1998-06-11
ZA885724B (en) 1989-04-26
AU2043388A (en) 1989-04-20
DK440888A (da) 1989-02-08
GR3003733T3 (es) 1993-03-16
FI883643A0 (fi) 1988-08-04
NO883468D0 (no) 1988-08-04
US5091365A (en) 1992-02-25
EP0302466B1 (de) 1991-11-21
DE3726324A1 (de) 1989-02-16
HU199301B (en) 1990-02-28
IE60871B1 (en) 1994-08-24
PT88192A (pt) 1989-06-30
NZ225715A (en) 1991-02-26
DE3866307D1 (de) 1992-01-02
EP0302466A1 (de) 1989-02-08
AU608878B2 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
YU69603A (sh) Atorvastatin kalcijum u farmaceutskom obliku, njegovoj smeši i farmaceutskoj formulaciji, koja sadrži atorvastatin kalcijum
MX9504034A (es) Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
FR2627696B1 (fr) Nouvelle forme galenique du fenofibrate
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
SE8700499D0 (sv) Novel pharmacologically active compounds
EA199700260A1 (ru) Готовая препаративная форма 2-метилтиенобензодиазепина для перорального введения и способ ее получения
MX9305146A (es) Conjugado de interferon, procedimiento para su preracion y composicion farmaceutica que lo contienen.
ES2190244T3 (es) Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales.
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
ES2038725T3 (es) Empleo de una sustancia auxiliar a base de ciclopeptidos y procedimiento para producir un preparado que la contiene.
SE9801495D0 (sv) Protein formulationa
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
ES525441A0 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
MX159874A (es) Procedimiento para preparar una composicion farmaceutica a base de fosfolipidos
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ES2071636T3 (es) Uso de acidos oxapenem-3-carboxilicos estables para la fabricacion de medicamentos inhibidores de la b-lactamasa.
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ES2072270T3 (es) Agente farmaceutico administrable por via oral, especialmente para la terapia de substitucion de hierro y de magnesio.
SE8603517D0 (sv) Heterocyclic compounds and their preparation and pharmaceutical formulation
ES2116452T3 (es) Composiciones farmaceuticas que comprenden agonistas de receptores 5ht1 y potenciadores de la absorcion.
IT1259140B (it) Formulazioni farmaceutiche per la somministraziane orale di calcitonina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 302466

Country of ref document: ES